These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Neurocysticercosis: up-dating in diagnosis and treatment]. Del Brutto OH Neurologia; 2005 Oct; 20(8):412-8. PubMed ID: 16217690 [TBL] [Abstract][Full Text] [Related]
3. Medical management of neurocysticercosis. Takayanagui OM; Odashima NS; Bonato PS; Lima JE; Lanchote VL Expert Opin Pharmacother; 2011 Dec; 12(18):2845-56. PubMed ID: 22082143 [TBL] [Abstract][Full Text] [Related]
4. Drug treatment of neurocysticercosis. Garg RK Natl Med J India; 1997; 10(4):173-7. PubMed ID: 9325640 [TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy of cysticercosis. Review about its pharmacokinetics and toxicology]. Herrera LA; Benítez-Bribiesca L; Sotelo J; Ostrosky-Wegman P Gac Med Mex; 2000; 136(5):477-89. PubMed ID: 11080931 [TBL] [Abstract][Full Text] [Related]
6. Neurocysticercosis. Singhi P; Suthar R Indian J Pediatr; 2015 Feb; 82(2):166-71. PubMed ID: 25297641 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic optimisation of the treatment of neurocysticercosis. Sotelo J; Jung H Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011 [TBL] [Abstract][Full Text] [Related]
8. Update on the diagnosis and management of neurocysticercosis. Takayanagui OM; Haes TM Arq Neuropsiquiatr; 2022 May; 80(5 Suppl 1):296-306. PubMed ID: 35976305 [TBL] [Abstract][Full Text] [Related]
9. Therapy for neurocysticercosis. Takayanagui OM Expert Rev Neurother; 2004 Jan; 4(1):129-39. PubMed ID: 15853623 [TBL] [Abstract][Full Text] [Related]
10. Neurocysticercosis. An introduction with special emphasis on new developments in pharmacotherapy. Overbosch D Schweiz Med Wochenschr; 1992 Jun; 122(23):893-8. PubMed ID: 1615299 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis. Jung-Cook H Expert Rev Clin Pharmacol; 2012 Jan; 5(1):21-30. PubMed ID: 22142156 [TBL] [Abstract][Full Text] [Related]
12. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. Singhi P; Ray M; Singhi S; Khandelwal N J Child Neurol; 2000 Apr; 15(4):207-13. PubMed ID: 10805184 [TBL] [Abstract][Full Text] [Related]
13. [Neurocysticercosis diagnosis and management in Peru]. Saavedra H; Gonzales I; Alvarado MA; Porras MA; Vargas V; Cjuno RA; Garcia HH; Martinez SM Rev Peru Med Exp Salud Publica; 2010; 27(4):586-91. PubMed ID: 21308200 [TBL] [Abstract][Full Text] [Related]
14. [Results of sequential prolonged courses of albendazole and praziquantel in recurrent neurocysticercosis]. Alla P; Carli P; Paris JF; Chagnon A Med Trop (Mars); 1996; 56(3):308. PubMed ID: 9026603 [No Abstract] [Full Text] [Related]
15. [Neurocysticercosis complicating the treatment of cutaneous cysticercosis in a traveller]. Epelboin L; Klement E; Chemali N; Danis M; Bricaire E; Caumes E Bull Soc Pathol Exot; 2004 Nov; 97(4):250-2. PubMed ID: 17304744 [TBL] [Abstract][Full Text] [Related]